Previous funding

• ARRS BI-US/09-12/013: Disturbed progesterone metabolism in endometriosis and endometrial cancer, 1.7.2009 - 30.6.2012

• LEK: PCR array expression analysis of drug transporters, 1.2.2011 - 30.11.2011

• HealthCare, BayerScheringPharma: From targets to novel drugs - endometriosis, 1.7.2009 - 30.6.2010

• ARRS J3-9448 -0381-07: Molecular basis of endometriosis and endometrial cancer, 1.7.2007 - 31.6.2010

• Solvay Pharmaceuticals GmbH, Germany: Evaluation of inhibitory potency of progestins, 1.11.2008-1.5.2009

• ARRS P1-0170-0381-04: Molecular mechanism of regulation of cellular processes in correlation with human disease, 1.1.2004 - 31.12.2008

• Lek: Cloning, expression and isolation of 13C and 15N labelled or unlabelled enzymes, 15.11.2007 - 15.11.2008

• Lek: Cloning, expression and isolation of Mur ligases and preparation of 13C and15N labelled MurD, 1.10.2006 - 30.9.2007

• ARRS- L3-6226-0381-04: Endometriosis and endometrial cancer: preparation of in vitro model and identification of novel drug targets, 1.2.2004 – 31.1.2007

• ARRS BI-US/05-06/003: Role of human aldo-keto reductase AKR1C1 in endometriosis and endometrial cancer, 1.1.2005-31.12.2006

• Solvay Pharmaceuticals GmbH, Germany: Gene expression analysis of human endometriotic tissue, 1.9.2004-31.8.2005

• NATO CLG project 980130: Role of 17beta-hydroxysteroid dehydrogenases in endometriosis and endometrial cancer, 11.8.2003-11.8. 2005

• MŠZŠ BI-US/03-04/11: Role of human aldo-keto reductases in progesterone metabolism, 1.1.2003-31.12.2004

• MŠZŠ SLO-US-2001/39: Role of human aldo-keto reductases in steroid receptor modulation, 1.4.2001-31.3. 2003

• NATO CLG project 97624830: Analysis of steroid signalling pathway in fungi: role of 17beta-hydroxysteroid dehydrogenase, 1.12.1999-30.11.2001